Zobrazeno 1 - 10
of 961
pro vyhledávání: '"Yoshio Hayashi"'
Autor:
Hiroaki Miyauchi, Koshu Okubo, Kiriko Iida, Hiroshi Kawakami, Kentaro Takayama, Yoshio Hayashi, Junji Haruta, Junichi Sasaki, Kaori Hayashi, Junichi Hirahashi
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Crush syndrome, which frequently occurs in earthquake disasters, often leads to rhabdomyolysis induced acute kidney injury (RIAKI). Recent findings indicate that systemic inflammatory response syndrome (SIRS) exacerbates muscle collapse, contributing
Externí odkaz:
https://doaj.org/article/2a61a59683c848548f7783e09a80f5f8
Publikováno v:
Pharmaceuticals, Vol 16, Iss 3, p 397 (2023)
Sarcopenia is a major public health issue that affects older adults. Myostatin inhibitory-D-peptide-35 (MID-35) can increase skeletal muscle and is a candidate therapeutic agent, but a non-invasive and accessible technology for the intramuscular deli
Externí odkaz:
https://doaj.org/article/8a506897109947f2b6f7104b334ec1af
Autor:
Kyohei Muguruma, Konomi Fujita, Akane Fukuda, Satoshi Kishimoto, Soichiro Sakamoto, Risako Arima, Mayu Ito, Mayu Kawasaki, Shogo Nakano, Sohei Ito, Kanade Shimizu, Akihiro Taguchi, Kentaro Takayama, Atsuhiko Taniguchi, Yuji Ito, Yoshio Hayashi
Publikováno v:
ACS Omega, Vol 4, Iss 11, Pp 14390-14397 (2019)
Externí odkaz:
https://doaj.org/article/86504a125b354796878b3cd771ed76b5
Autor:
Hayate Shida, Akihiro Taguchi, Sho Konno, Kentaro Takayama, Atsuhiko Taniguchi, Yoshio Hayashi
Publikováno v:
Chemical and Pharmaceutical Bulletin. 71:435-440
Autor:
Hideyuki Okamoto, Shuko Amber Murano, Kaoru Ikekawa, Masahiro Katsuyama, Sho Konno, Akihiro Taguchi, Kentaro Takayama, Atsuhiko Taniguchi, Yoshio Hayashi
Publikováno v:
RSC Medicinal Chemistry. 14:386-392
Myostatin-binding d-peptides functionalized with photocatalyst efficiently inactivate myostatin by photooxygenation and show no phototoxicity and high resistance to proteolytic enzymes, leading to the treatment of muscular atrophic diseases.
Autor:
Hironobu Murakami, Yuuta Fujikawa, Masaya Mori, Nozomi Mosu, Akihiro Taguchi, Yoshio Hayashi, Hideshi Inoue, Shinji Kamisuki
Publikováno v:
Bioscience, Biotechnology & Biochemistry; Sep2023, Vol. 87 Issue 9, p946-953, 8p
Autor:
Yan Cui, Akihiro Taguchi, Hayate Shida, Sho Konno, Kentaro Takayama, Atsuhiko Taniguchi, Yoshio Hayashi
Publikováno v:
Bulletin of the Chemical Society of Japan. 95:1156-1162
Autor:
Kentaro Takayama, Keisuke Hitachi, Hideyuki Okamoto, Mariko Saitoh, Miki Odagiri, Rina Ohfusa, Takahiro Shimada, Akihiro Taguchi, Atsuhiko Taniguchi, Kunihiro Tsuchida, Yoshio Hayashi
Publikováno v:
ACS Med Chem Lett
[Image: see text] Myostatin is a key negative regulator of skeletal muscle growth, and myostatin inhibitors are attractive tools for the treatment of muscular atrophy. Previously, we reported a series of 14–29-mer peptide myostatin inhibitors, incl
Publikováno v:
Practica oto-rhino-laryngologica. Suppl.. 158:119-121
Autor:
Chika Azuma, Shunsuke Sawamura, Kohei Tsuji, Hirokazu Tamamura, Takuya Kobayakawa, Atsuhiko Taniguchi, Yuki Watanabe, Yoshio Hayashi
Publikováno v:
The Journal of Organic Chemistry. 86:5091-5101
Improved methods of convergent synthesis for peptidomimetic utilizing a chloroalkene dipeptide isostere (CADI) are reported. In this synthesis, Fmoc- or Boc-protected carboxylic acids can be produced from N- and C-terminal analogues corresponding to